| abstract |
Compositions for use in the treatment or prevention of an influenza infection are provided, and the compositions contain a 2-fucosylated oligosaccharide, such as 2'-fucosyl lactose (2'FL). The compositions may also include fructooligosaccharides (FOS). Additionally, such compositions can be used to improve resistance to an influenza virus, decrease influenza in the lungs, decrease influenza-induced anorexia, decrease influenza-induced pulmonary mucin secretion, and decrease influenza-induced lgG response. These can be used in an infant or a small child. |